Characterization of the Variability of Insulin Secretory Parameters in the Meal Tolerance and the Maximal Stimulation Tests of Healthy Subjects

CompletedOBSERVATIONAL
Enrollment

25

Participants

Timeline

Start Date

October 31, 2011

Primary Completion Date

January 31, 2012

Study Completion Date

January 31, 2012

Conditions
Type 2 Diabetes
Trial Locations (1)

78209

ICON Development Solutions, Gault Lane, San Antonio

All Listed Sponsors
collaborator

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

NIH

collaborator

Juvenile Diabetes Research Foundation

OTHER

collaborator

Amylin Pharmaceuticals, LLC.

INDUSTRY

collaborator

Merck Sharp & Dohme LLC

INDUSTRY

collaborator

Pfizer

INDUSTRY

collaborator

Eli Lilly and Company

INDUSTRY

collaborator

Takeda

INDUSTRY

collaborator

Johnson & Johnson Pharmaceutical Research & Development, L.L.C.

INDUSTRY

collaborator

Novartis

INDUSTRY

lead

Foundation for the National Institutes of Health

OTHER